What’s the Problem?
According to an FDA Recall Notice, this action affects:
- Metformin Hydrochloride Extended-Release Tablets, USP 500 mg, white to off-white capsule shaped tablets, debossed with an Andrx logo with “571”on one side and “500” on the opposite side.
- Metformin Hydrochloride Extended-Release Tablets, USP 750 mg, light yellow capsule shaped tablets, debossed with an Andrx logo with “577” on one side and “750” on the opposite side.
Teva Pharmaceuticals recalled the metformin after FDA testing revealed the presence of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit (ADI). NDMA is a known environmental contaminant that has been classified as a “probable human carcinogen (a substance that could cause cancer),” according to the FDA.
If you were prescribed any metformin that is affected by this recall, you should not stop taking it without consulting your physician, as doing so could result in severe health complications. This recall began on June 2, 2020.
Do I Have an Actavis Metformin Recall Lawsuit?
The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Actavis Metformin Recall Lawsuits. We are handling individual litigation nationwide and currently accepting new cancer cases in all 50 states.
If you or a loved one has been injured by recalled metformin, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.